Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this multicenter, randomized, open label, parallel arm study whether the newest 3rd generation stent - Orsiro hybrid sirolimus-eluting stent is noninferior to the newest 2nd generation stent - Resolute Integrity zotarolimus-eluting stent in terms of 9 months in-stent late lumen loss. 345 Korean patients with a wide variety of coronary heart disease will be enrolled to this \"all-comers\" trial to give definite answer to the above hypothesis that is urgently needed.
Epistemonikos ID: e4f05ccaf560e66acd8dfd2b439a10a7209f24cc
First added on: May 11, 2024